Publication of UK REACH's priorities for upcoming year prompts concern of growing regulatory gap between EU and UK on hazardous chemical regulation.
The Government says the GSD's analysis of the reciprocal healthcare arrangements is total nonsense and shows lack of understanding.
Restrictions on doctors’ working hours must not be watered down as part of post-Brexit legislative changes, the BMA has said.
NICOLA Sturgeon has said Brexit is making recruitment of oncologists and radiologists "more challenging" as she was pressed on NHS waiting times by Douglas Ros at FMQs.
Refusal to nominate speaker derails legislature and raises stakes in London’s dispute with Brussels
‘This flies in the face of common sense and the government’s commitment to high levels of animal and human health,’ say experts.
Commenting on reports that the Prime Minister has indicated that post-Brexit checks on food imports from the EU to Great Britain are to be delayed for a fourth time, the British Veterinary Association has reiterated a stark warning over disease threats.
Brexit comes with uncertainty regarding the approval of medicines and medical devices, including software and technology. Regulatory hurdles could disrupt the approval of existing and new devices and technology.
Vets warn delay to post-Brexit checks will ‘open door to African Swine Fever’ and other diseases 30/03/2022
‘Deeply misguided’ to ‘weaken this layer of protection for both animal and public health’, government told.
American agricultural lobby groups had criticised some of the import bans.
Brexit keeps Gibraltar ambulances off Spain 07/03/2022
In a new direct Brexit spinoff, authorities at the British Overseas Territory of Gibraltar have confirmed that routine patients may henceforth be ferried for treatment to Spanish hospitals only if their ambulances are staffed by Gibraltar Health Authority (GHA) employees who live in Spain or by EU nationals, it was reported.
The government has said it could use its new Brexit "freedoms" to ditch planned EU car safety regulations. / Package of measures aimed to reduce head injuries and pedestrian deaths.
Post-Brexit issues for the NHS 19/01/2022
There are a number of measures that the UK Government must take in order to address the challenges of leaving the EU's single market.
Nuffield Trust: Slow decisions and vague trade slogans leave NHS uncertain of post-Brexit future 20/12/2021
Our report published today looks at six key areas of health and social care that are being impacted by Brexit.
Brexit uncertainty adds another dimension of disruption to a health service already struggling with the unknown legacy of a global pandemic
The government is planning to water down the regulatory requirements on key chemicals, in what experts fear could be the first move to a weaker post-Brexit safety regime for potentially toxic substances.
52 people in Cork and Kerry waiting for wheelchairs due to Brexit and supply chain delays 13/12/2021
MORE than 50 people are on waiting lists for wheelchairs across Cork and Kerry amid calls for greater funding and resourcing to ensure people are not left facing major delays.
RESEARCH experts and charities working with people with serious and often terminal illnesses have said that delays to research and clinical trials from Brexit could mean the difference between "life or death" for patients.
End-of-life patients being cared for at home are having to wait for bedsore-relieving equipment, one family member has said.
The government would do well to read the House of Lords EU committee report on Brexit impacts, recently debated in the Lords.
The U.K. government’s preparations for a no-deal Brexit took “significant time and resources” away from planning for a potential pandemic, a major report found.
A new report urges consideration of public health and well-being in post-Brexit trade agreements to avoid making existing health and inequalities in Wales worse.
IN September 2019, the UK Government made public its list of “reasonable worst case assumptions” in the wake of a no-deal Brexit.
Informa Pharma Intelligence (IPI) has found that some drug firms may withdraw up to 90% of their products from Northern Ireland, once the Brexit grace period has passed.